Clinical trial
Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
NCT04386317
Study timeline
Study start (actual)2020-11-01Date precision: day
Registry last updated2026-03-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
REM Sleep Behavior Disorderunresolved
Pre-motor Parkinson's Diseaseunresolved
Symptomatic Parkinson Diseaseunresolved
Interventions
TerazosinDRUG · verified · RxNorm: terazosin
Sponsors & collaborators
Cedars-Sinai Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04386317 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.